Pfizer (PFE) PT Lowered to $45 at BofA/Merrill Lynch
Tweet Send to a Friend
BofA/Merrill Lynch analyst Jason Gerberry ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
